RPTOR and prostate cancer: Since knocking down cdk1, cyclin B, or Raptor led to a significant reduction of tumor growth in the present study, it seems likely that diminishing these proteins may constitute a crucial mechanism (among others) explaining how VPA slows down the proliferative activity of prostate cancer cells.